Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

3,607 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
A double-blind randomized placebo-controlled withdrawal trial comparing memantine and antipsychotics for the long-term treatment of function and neuropsychiatric symptoms in people with Alzheimer's disease (MAIN-AD).
Ballard C, Thomas A, Gerry S, Yu LM, Aarsland D, Merritt C, Corbett A, Davison C, Sharma N, Khan Z, Creese B, Loughlin P, Bannister C, Burns A, Win SN, Walker Z; MAIN-AD investigators. Ballard C, et al. Among authors: khan z. J Am Med Dir Assoc. 2015 Apr;16(4):316-22. doi: 10.1016/j.jamda.2014.11.002. Epub 2014 Dec 15. J Am Med Dir Assoc. 2015. PMID: 25523285 Clinical Trial.
Nonpharmacological treatment of Alzheimer disease.
Ballard C, Khan Z, Clack H, Corbett A. Ballard C, et al. Among authors: khan z. Can J Psychiatry. 2011 Oct;56(10):589-95. doi: 10.1177/070674371105601004. Can J Psychiatry. 2011. PMID: 22014691 Review.
Impact of Antipsychotic Review and Nonpharmacological Intervention on Antipsychotic Use, Neuropsychiatric Symptoms, and Mortality in People With Dementia Living in Nursing Homes: A Factorial Cluster-Randomized Controlled Trial by the Well-Being and Health for People With Dementia (WHELD) Program.
Ballard C, Orrell M, YongZhong S, Moniz-Cook E, Stafford J, Whittaker R, Woods B, Corbett A, Garrod L, Khan Z, Woodward-Carlton B, Wenborn J, Fossey J. Ballard C, et al. Among authors: khan z. Am J Psychiatry. 2016 Mar 1;173(3):252-62. doi: 10.1176/appi.ajp.2015.15010130. Epub 2015 Nov 20. Am J Psychiatry. 2016. PMID: 26585409 Clinical Trial.
Impact of antipsychotic review and non-pharmacological intervention on health-related quality of life in people with dementia living in care homes: WHELD-a factorial cluster randomised controlled trial.
Ballard C, Orrell M, Sun Y, Moniz-Cook E, Stafford J, Whitaker R, Woods B, Corbett A, Banerjee S, Testad I, Garrod L, Khan Z, Woodward-Carlton B, Wenborn J, Fossey J. Ballard C, et al. Among authors: khan z. Int J Geriatr Psychiatry. 2017 Oct;32(10):1094-1103. doi: 10.1002/gps.4572. Epub 2016 Sep 19. Int J Geriatr Psychiatry. 2017. PMID: 27640872 Clinical Trial.
Epidemiology of Pain in People With Dementia Living in Care Homes: Longitudinal Course, Prevalence, and Treatment Implications.
Rajkumar AP, Ballard C, Fossey J, Orrell M, Moniz-Cook E, Woods RT, Murray J, Whitaker R, Stafford J, Knapp M, Romeo R, Woodward-Carlton B, Khan Z, Testad I, Corbett A. Rajkumar AP, et al. Among authors: khan z. J Am Med Dir Assoc. 2017 May 1;18(5):453.e1-453.e6. doi: 10.1016/j.jamda.2017.01.024. Epub 2017 Mar 18. J Am Med Dir Assoc. 2017. PMID: 28330634
Evaluation of the safety, tolerability, and efficacy of pimavanserin versus placebo in patients with Alzheimer's disease psychosis: a phase 2, randomised, placebo-controlled, double-blind study.
Ballard C, Banister C, Khan Z, Cummings J, Demos G, Coate B, Youakim JM, Owen R, Stankovic S; ADP Investigators. Ballard C, et al. Among authors: khan z. Lancet Neurol. 2018 Mar;17(3):213-222. doi: 10.1016/S1474-4422(18)30039-5. Lancet Neurol. 2018. PMID: 29452684 Clinical Trial.
3,607 results